Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Tufik R. Assad"'
Autor:
Kurt W. Prins, Rajat Kalra, Lauren Rose, Tufik R. Assad, Stephen L. Archer, Navkaranbir S. Bajaj, E. Kenneth Weir, Sasha Z. Prisco, Marc Pritzker, Pamela L. Lutsey, Evan L. Brittain, Thenappan Thenappan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 5 (2020)
Background Pulmonary arterial hypertension (PAH) is a lethal disease. In resource‐limited countries PAH outcomes are worse because therapy costs are prohibitive. To improve global outcomes, noninvasive and widely available biomarkers that identify
Externí odkaz:
https://doaj.org/article/8e82535fe49747acb0b42fcc5f11da4a
Autor:
Vineet Agrawal, Michele D'Alto, Robert Naeije, Emanuele Romeo, Meng Xu, Tufik R. Assad, Ivan M. Robbins, John H. Newman, Meredith E. Pugh, Anna R. Hemnes, Evan L. Brittain
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 17 (2019)
Background Identification of occult diastolic dysfunction often requires invasive right heart catheterization with provocative maneuvers such as fluid challenge. Non‐invasive predictors of occult diastolic dysfunction have not been identified. We h
Externí odkaz:
https://doaj.org/article/25e449f7e94d4f39b3ad78611b7c3b84
Autor:
Stephen J. Halliday, Meng Xu, Timothy E. Thayer, Jonathan D. Mosley, Quanhu Sheng, Fei Ye, Eric H. Farber-Eger, Meredith E. Pugh, Ivan R. Robbins, Tufik R. Assad, James D. West, Evan L. Brittain, Anna R. Hemnes
Publikováno v:
Pulmonary Circulation, Vol 8 (2018)
Parenteral prostacyclin therapy is the most efficacious pharmacologic treatment for pulmonary arterial hypertension (PAH), but clinical response is variable. We sought to identify clinical, hemodynamic, and genetic associations with response to prost
Externí odkaz:
https://doaj.org/article/a1d445a1829e4de68b19bd195af26586
Autor:
Jared M. O'Leary, Tufik R. Assad, Meng Xu, Eric Farber‐Eger, Quinn S. Wells, Anna R. Hemnes, Evan L. Brittain
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 13 (2018)
Background Transthoracic echocardiography (TTE) is used to estimate pulmonary artery systolic pressure, but an adequate tricuspid regurgitation velocity (TRV) needed to calculate pulmonary artery systolic pressure is not always present. It is unknown
Externí odkaz:
https://doaj.org/article/91abb06b07a2453aab2b49f09ed73158
Autor:
Bin Q. Yang, Tufik R. Assad, Jared M. O'Leary, Meng Xu, Stephen J. Halliday, Reid W. D'Amico, Eric H. Farber-Eger, Quinn S. Wells, Anna R. Hemnes, Evan L. Brittain
Publikováno v:
Pulmonary Circulation, Vol 8 (2018)
African Americans (AA) have a higher incidence of pulmonary hypertension (PH) risk factors. Few studies have examined the racial differences in the prevalence and etiology of PH and direct comparison of invasive hemodynamics between AAs and Caucasian
Externí odkaz:
https://doaj.org/article/43fa36ae57a14152abfaeac3f615f618
Autor:
Jared M. O’Leary, Tufik R. Assad, Meng Xu, Kelly A. Birdwell, Eric Farber-Eger, Quinn S. Wells, Anna R. Hemnes, Evan L. Brittain
Publikováno v:
Pulmonary Circulation, Vol 7 (2017)
Pulmonary hypertension (PH) is common in patients with chronic kidney disease (CKD) and associated with increased mortality but the hemodynamic profiles, clinical risk factors, and outcomes have not been well characterized. Our objective was to defin
Externí odkaz:
https://doaj.org/article/aeaeb7204891477faf2aa82afb90633e
Autor:
Tufik R. Assad, Meredith E. Pugh, Anna R. Hemnes, Vineet A Agrawal, Ryan J Tedford, Amelia Muhs, John H. Newman, Vineet Agrawal, Evan L. Brittain, Ivan M. Robbins
Publikováno v:
Circulation. 142
Introduction: Fluid challenge during right heart catheterization (RHC) identifies occult left heart diastolic dysfunction (Occ-DD) in 10-20% of patients initially diagnosed with pre-capillary pulmonary hypertension (PH). The prognostic implications o
Autor:
Timothy E. Thayer, Rebecca T. Levinson, Eric Farber-Eger, Jonathan D. Mosley, Tufik R. Assad, Quinn S. Wells, Evan L. Brittain, Shi Huang
Publikováno v:
Chest
Background There is an unclear relationship of obesity to the pathogenesis and severity of pulmonary arterial hypertension (PAH) and pulmonary venous hypertension (PVH). Research Question Is BMI casually associated with pulmonary artery pressure (PAP
Autor:
Christopher J. Rhodes, Anna Ulrich, William C. Nichols, Tufik R. Assad, Richard C. Trembath, Martin R. Wilkins, Lars Harbaum, Stefan Gräf, Marc Humbert, David-Alexandre Trégouët, John Wharton, Florent Soubrier, Ankit A. Desai, Nicholas W. Morrell, Inga Prokopenko, Emilia M. Swietlik, Evan L. Brittain, Laura Southgate, Timothy E. Thayer
Publikováno v:
The European Respiratory Journal
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2020, 55 (2), pp.1901486. ⟨10.1183/13993003.01486-2019⟩
European Respiratory Journal, 2020, 55 (2), pp.1901486. ⟨10.1183/13993003.01486-2019⟩
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2020, 55 (2), pp.1901486. ⟨10.1183/13993003.01486-2019⟩
European Respiratory Journal, 2020, 55 (2), pp.1901486. ⟨10.1183/13993003.01486-2019⟩
Pulmonary arterial hypertension (PAH) is a rare disease that leads to premature death from right heart failure. It is strongly associated with elevated red cell distribution width (RDW), a correlate of several iron status biomarkers. High RDW values
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f68215cca1569b0b16cadaf215507e6
http://hdl.handle.net/20.500.12278/26324
http://hdl.handle.net/20.500.12278/26324
Autor:
George A. Alba, Gabor Kovacs, Ronald H. Goldstein, Tufik R. Assad, Gaurav Choudhary, Horst Olschewski, Ryan J. Tedford, Gérald Simonneau, Bradley A. Maron, Bradley M. Wertheim, Stephen W. Waldo, Marc Humbert, Anna E. Barón, Jane A. Leopold, Evan L. Brittain, Shi Huang, Nazzareno Galiè, Edward Hess
Background: In pulmonary hypertension subgroups, elevated pulmonary vascular resistance (PVR) of 3·0 Wood units or more is associated with poor prognosis. However, the spectrum of PVR risk in pulmonary hypertension is not known. To address this area
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e30d6399439dcb90e8718c17b87c6530
http://hdl.handle.net/11585/863644
http://hdl.handle.net/11585/863644